ArticlePLoS pathogens2026
HSV ICP27 hijacks host splicing factor SRSF3 to regulate pre-mRNA splicing and export for viral gene expression and immune evasion.
Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
HSV ICP27, a multifunctional essential immediate early (IE) viral protein, regulates both viral and host pre-mRNA processing in a gene/sequence-specific manner. Using viral mutagenesis studies, we investigated the mechanisms underlying ICP27-mediated co-transcriptional splicing inhibition. We report that ICP27 inhibits pre-mRNA splicing by hijacking host serine/arginine-rich splicing factor 3 (SRSF3), which binds to an exonic ICP27/SRSF3-responsive motif near the 5' splice site of targeted transcripts, revealing that interaction with SRSF3 enhances both target specificity and efficiency of ICP27-mediated aberrant splicing, in a way independent of its RNA-binding RGG domain. Furthermore, ICP27 co-opts SRSF3 to promote nuclear-export of unspliced mRNA targets via the nuclear RNA export factor 1 (NXF1). Viruses with mutations both in the ICP27 N-terminal nuclear export signal (NES), via which ICP27 interacts with NXF1, and in the RGG RNA-binding domain, are defective in ICP27-mediated splicing inhibition, expression of ICP27-dependent genes, and viral growth, revealing that ICP27-mediated nuclear export of unspliced mRNA is indispensable for ICP27-mediated splicing inhibition and gene expression. Preventing U1 small nuclear ribonucleoprotein (U1 snRNP) binding by knockdown of U1-70K, a component of U1 snRNP that binds to the 5' splice site, led both to splicing inhibition and to enhanced expression of ICP27-dependent genes. Together, these results suggest a spatiotemporal role for ICP27 in regulating sequence-specific pre-mRNA splicing by hijacking SRSF3, preventing spliceosome formation, and subsequently promoting nuclear export of aberrantly processed mRNAs containing restrictive elements including intact 5' splice sites, which would otherwise be detained, spliced or degraded in the nucleus. We hypothesize that during latency, HSV likely takes advantage of the host mRNA processing machinery to restrict expression of randomly activated antigenic viral genes to achieve immune evasion when ICP27 is absent during latency. Upon reactivation, ICP27 is essential for ensuring both the quality and quantity of viral gene expression, enabling optimal viral replication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.